Cite
HARVARD Citation
Stamoulos, P. et al. (n.d.). Azathioprine/allopurinol co-therapy is an effective treatment for patients with inflammatory bowel disease who exhibit no response or side-effects to thiopurines without the need for metabolite level measurements. Gut. pp. A218-A219. [Online].